Moreover, increased Tim3 expression on tumor-specific CD8+ T cells was associated with impaired CD8+ T cell function and poor prognosis in HBV-associated hepatocellular carcinoma (60) and prostate cancer (61). This evidence concerns the gene HAVCR2 and prostate carcinoma.